ORGS OTC
Orgenesis Inc.
1W: +16.0%
1M: +65.7%
3M: +45.0%
YTD: +286.7%
1Y: -26.6%
3Y: -90.7%
5Y: -98.8%
$0.58
+0.03 (+5.45%)
Weekly Expected Move ±739.3%
$-8
$-4
$1
$5
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$530K
-98.5% ▼
5Y CAGR: -50.9%
Gross Profit
-$6M
-136.7% ▼
Operating Income
-$54M
-611.3% ▼
Net Income
-$55M
-271.8% ▼
EPS (Diluted)
$-1.91
-223.7% ▼
EBITDA
-$61M
-644.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $33M | $8M | $36M | $36M | $530K |
| YoY Growth | +78.3% | -77.0% | +364.0% | +1.5% | -98.5% |
| Cost of Revenue | $18M | $31M | $28M | $20M | $6M |
| Gross Profit | $15M | -$23M | $7M | $16M | -$6M |
| Gross Margin | 45.5% | -306.4% | 20.7% | 43.3% | -1080.2% |
| R&D Expenses | $12M | $84M | $37M | $6M | $11M |
| SG&A Expenses | $25M | $19M | $15M | $16M | $35M |
| Operating Expenses | $40M | $103M | $50M | $23M | $48M |
| Operating Income | -$25M | -$96M | -$17M | -$8M | -$54M |
| Operating Margin | -74.0% | -1251.7% | -47.3% | -20.9% | -10120.0% |
| Interest Expense | $461K | $1M | $369K | $2M | $2M |
| Income Before Tax | -$25M | -$97M | -$18M | -$12M | -$64M |
| Tax Expense | $563K | -$2M | $108K | $209K | $473K |
| Net Income | -$26M | -$96M | -$18M | -$15M | -$55M |
| Net Margin | -78.3% | -1252.1% | -50.9% | -41.3% | -10445.5% |
| EPS (Diluted) | $-1.64 | $-4.46 | $-0.74 | $-0.59 | $-1.91 |
| EBITDA | -$19M | -$94M | -$16M | -$8M | -$61M |
| Shares Outstanding | 16M | 21M | 24M | 25M | 29M |